Prostate Cancer Treatment Cookeville TN
Oncology (Cancer), Radiation Oncology
Medical School: Loyola Univ Of Chicago Stritch Sch Of Med, Maywood Il 60153
Graduation Year: 1980
Graduation Year: 2007
Hematology / Oncology
Cookeville Regional Cancer Ctr
Medical School: Bangalore Med Coll, Bangalore Univ, Bangalore, Karnataka, India
Graduation Year: 1961
Hospital: St Jude Childrens Res Hosp, Memphis, Tn; Methodist Health -Le Bonheur, Memphis, Tn
Oncology (Cancer), Hematology-Internal Medicine
Medical School: Univ Of Tn, Memphis, Coll Of Med, Memphis Tn 38163
Graduation Year: 1974
Medical School: Univ Of Il Coll Of Med, Chicago Il 60680
Graduation Year: 1970
Cookeville Reg Cancer Ctr
Pediatric and Adult Urology
Urology, Incontinence, Oncology, Infertility
Insurance Plans Accepted: All insurances accepted
Primary Hospital: Gateway Medical Center
Residency Training: Georgetown University, New York Medical College
Medical School: Georgetown University School of Medicine, Washington, DC, 1988
Languages Spoken: English,Spanish
Heal Thyself—Prostate Cancer
By Barbara Hey
Turning up the heat may provide a less invasive, more promising treatment for prostate cancer. Blasting the cancer with a treatment that uses high-intensity focused ultrasound (HIFU) to kill cancer cells and surrounding prostate tissue offers myriad benefits over conventional treatments according to John Warner, MD, the medical director of the Maple Leaf HIFU Company in Vancouver, British Columbia. Maple Leaf HIFU manufactures Ablatherm HIFU, the machine currently used for this procedure.
• HIFU can be performed under a spinal block—versus general anesthesia—most often on an outpatient basis, Warner explains, with no incision and no attendant loss of blood. Studies confirm HIFU’s effectiveness in combating the disease, and because it’s noninvasive, the procedure is less likely to damage surrounding nerves and tissue. A study published in the Journal of Urology in 2003 found that five years after treatment, 87 percent of patients had stable prostate specific antigen (PSA) levels. High or rising levels suggest the presence of the disease.
• If treated early, before it spreads, prostate cancer has a nearly 100 percent five-year survival rate, according to the Prostate Cancer Foundation. Though the common methods of treatment (radiation and surgery) work effectively, they have a number of ser-ious risks associated with them. With radiation administered externally—called external beam radiotherapy—the beam can damage surrounding tissue, skin, and muscle en route to the prostate, and patients commonly require multiple treatments. Another option is brachytherapy in which radioactive pellets are inserted surgically into the prostate. The risk of this type of radiation is that the effects can extend beyond the prostate itself. A third option, surgery, requires general anesthesia and hospitalization, which both carry risks. A much more aggressive tactic, surgery involves not just removal of the prostate, but also portions of the seminal ducts and part of the bladder. Common aftereffects of all these treatments include impotence and incontinence.
• For the HIFU treatment, a probe is inserted in the rectum to guide the ultrasound to the prostate using computer imaging. The focused beam of sound reaches a heat of 85 degrees Celsius, killing the cells of the prostate (dead tissue is excreted later in the urine) while skirting the surrounding nerves and muscles. And according to Warner, 90 percent of the patients require just one treatment, which may last 90 minutes to three hours.
• Currently only the Don Mills Surgical Unit in Toronto offers Ablatherm HIFU treatment, but that may change in the near future. FDA-monitored studies comparing HIFU with cryotherapy (freezing the tissue, commonly used as a second-line of treatment) on patients with a recurrence of the disease will begin in 2006, setting the stage for the treatment to one day be available in the US.
Copyright 1999-2009 Natural Solutions: Vibrant Health, Balanced Living/Alternative Medicine/InnoVisi...